BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23499302)

  • 1. Cross-talk between SIRT1 and p66Shc in vascular diseases.
    Chen HZ; Wan YZ; Liu DP
    Trends Cardiovasc Med; 2013 Oct; 23(7):237-41. PubMed ID: 23499302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P66
    Kong X; Guan J; Li J; Wei J; Wang R
    Mol Neurobiol; 2017 Sep; 54(7):5277-5285. PubMed ID: 27578018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.
    Zhou S; Chen HZ; Wan YZ; Zhang QJ; Wei YS; Huang S; Liu JJ; Lu YB; Zhang ZQ; Yang RF; Zhang R; Cai H; Liu DP; Liang CC
    Circ Res; 2011 Sep; 109(6):639-48. PubMed ID: 21778425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence.
    Chen H; Wan Y; Zhou S; Lu Y; Zhang Z; Zhang R; Chen F; Hao D; Zhao X; Guo Z; Liu D; Liang C
    Sci China Life Sci; 2012 Jun; 55(6):467-73. PubMed ID: 22744176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of p66shc gene protects against age-related endothelial dysfunction.
    Francia P; delli Gatti C; Bachschmid M; Martin-Padura I; Savoia C; Migliaccio E; Pelicci PG; Schiavoni M; Lüscher TF; Volpe M; Cosentino F
    Circulation; 2004 Nov; 110(18):2889-95. PubMed ID: 15505103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuin1-regulated lysine acetylation of p66Shc governs diabetes-induced vascular oxidative stress and endothelial dysfunction.
    Kumar S; Kim YR; Vikram A; Naqvi A; Li Q; Kassan M; Kumar V; Bachschmid MM; Jacobs JS; Kumar A; Irani K
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1714-1719. PubMed ID: 28137876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice.
    Xu X; Hu Y; Zhai X; Lin M; Chen Z; Tian X; Zhang F; Gao D; Ma X; Lv L; Yao J
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):68-76. PubMed ID: 23993977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and oxidative stress-related diseases: the p66Shc connection.
    Pellegrini M; Baldari CT
    Curr Mol Med; 2009 Apr; 9(3):392-8. PubMed ID: 19355920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction.
    Magenta A; Greco S; Capogrossi MC; Gaetano C; Martelli F
    Biomed Res Int; 2014; 2014():193095. PubMed ID: 24734227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p66Shc deletion in age-associated arterial dysfunction and disease states.
    Camici GG; Cosentino F; Tanner FC; Lüscher TF
    J Appl Physiol (1985); 2008 Nov; 105(5):1628-31. PubMed ID: 18772327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial reactive oxygen species regulator p66Shc controls PDGF-induced signaling and migration through protein tyrosine phosphatase oxidation.
    Frijhoff J; Dagnell M; Augsten M; Beltrami E; Giorgio M; Östman A
    Free Radic Biol Med; 2014 Mar; 68():268-77. PubMed ID: 24378437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRIF1 deficiency induces p66shc-mediated oxidative stress and endothelial activation.
    Nagar H; Jung SB; Kwon SK; Park JB; Shong M; Song HJ; Jeon BH; Irani K; Kim CS
    PLoS One; 2014; 9(6):e98670. PubMed ID: 24906005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor?
    Gertz M; Steegborn C
    Antioxid Redox Signal; 2010 Nov; 13(9):1417-28. PubMed ID: 20214499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein protects against UVB-induced senescence-like characteristics in human dermal fibroblast by p66Shc down-regulation.
    Wang YN; Wu W; Chen HC; Fang H
    J Dermatol Sci; 2010 Apr; 58(1):19-27. PubMed ID: 20211546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p66 Shc as the engine of vascular aging.
    Paneni F; Cosentino F
    Curr Vasc Pharmacol; 2012 Nov; 10(6):697-9. PubMed ID: 23259557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The p53-p66shc-Manganese Superoxide Dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species.
    Pani G; Koch OR; Galeotti T
    Int J Biochem Cell Biol; 2009 May; 41(5):1002-5. PubMed ID: 18992840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes.
    Paneni F; Costantino S; Castello L; Battista R; Capretti G; Chiandotto S; D'Amario D; Scavone G; Villano A; Rustighi A; Crea F; Pitocco D; Lanza G; Volpe M; Del Sal G; Lüscher TF; Cosentino F
    Eur Heart J; 2015 Apr; 36(13):817-28. PubMed ID: 24801072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress.
    Natalicchio A; Tortosa F; Perrini S; Laviola L; Giorgino F
    Arch Physiol Biochem; 2011 Jul; 117(3):116-24. PubMed ID: 21506908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [P66shc action on resistance of colon carcinoma RKO cells to oxidative stress].
    Galimov ER; Sidorenko AS; Tereshkova AV; Pletiushkina OIu; Cherniak BV; Chumakov PM
    Mol Biol (Mosk); 2012; 46(1):139-46. PubMed ID: 22642111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.
    Albiero M; Poncina N; Tjwa M; Ciciliot S; Menegazzo L; Ceolotto G; Vigili de Kreutzenberg S; Moura R; Giorgio M; Pelicci P; Avogaro A; Fadini GP
    Diabetes; 2014 Apr; 63(4):1353-65. PubMed ID: 24270983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.